Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hydrocephalus | 48 | 2025 | 242 | 7.710 |
Why?
|
Fecal Incontinence | 32 | 2022 | 71 | 6.270 |
Why?
|
Meningomyelocele | 34 | 2025 | 251 | 4.460 |
Why?
|
Cerebrospinal Fluid Shunts | 30 | 2025 | 77 | 4.130 |
Why?
|
Fetoscopy | 35 | 2025 | 448 | 3.470 |
Why?
|
Irritable Bowel Syndrome | 13 | 2018 | 206 | 2.760 |
Why?
|
Neurosurgical Procedures | 25 | 2024 | 304 | 2.490 |
Why?
|
Biofeedback, Psychology | 18 | 2021 | 33 | 2.410 |
Why?
|
Neural Tube Defects | 19 | 2024 | 355 | 2.380 |
Why?
|
Constipation | 11 | 2019 | 115 | 1.860 |
Why?
|
Spinal Dysraphism | 12 | 2024 | 270 | 1.710 |
Why?
|
Ventriculoperitoneal Shunt | 13 | 2024 | 50 | 1.680 |
Why?
|
Gastrointestinal Diseases | 10 | 2023 | 336 | 1.640 |
Why?
|
Hysterotomy | 16 | 2025 | 126 | 1.600 |
Why?
|
Spina Bifida Cystica | 5 | 2024 | 35 | 1.530 |
Why?
|
Quality of Life | 24 | 2023 | 1935 | 1.520 |
Why?
|
Abdominal Pain | 10 | 2018 | 310 | 1.480 |
Why?
|
Ventriculostomy | 13 | 2024 | 35 | 1.450 |
Why?
|
Female | 203 | 2025 | 66565 | 1.340 |
Why?
|
Third Ventricle | 10 | 2024 | 27 | 1.260 |
Why?
|
Humans | 255 | 2025 | 124726 | 1.240 |
Why?
|
Anal Canal | 15 | 2021 | 81 | 1.130 |
Why?
|
Spinal Fusion | 13 | 2024 | 114 | 1.110 |
Why?
|
Proton Therapy | 8 | 2023 | 123 | 1.070 |
Why?
|
Exercise Therapy | 5 | 2021 | 153 | 1.060 |
Why?
|
Treatment Outcome | 69 | 2025 | 12357 | 1.050 |
Why?
|
Child | 97 | 2025 | 24384 | 1.000 |
Why?
|
Neuroendoscopy | 11 | 2024 | 25 | 0.980 |
Why?
|
Pregnancy | 50 | 2025 | 7178 | 0.980 |
Why?
|
Arnold-Chiari Malformation | 5 | 2024 | 50 | 0.970 |
Why?
|
Male | 137 | 2025 | 61267 | 0.970 |
Why?
|
Retrospective Studies | 71 | 2025 | 16334 | 0.960 |
Why?
|
Infant, Newborn | 50 | 2025 | 8191 | 0.960 |
Why?
|
Child, Preschool | 66 | 2025 | 14016 | 0.940 |
Why?
|
Equipment Failure | 7 | 2024 | 121 | 0.940 |
Why?
|
Cerebellar Neoplasms | 8 | 2024 | 275 | 0.920 |
Why?
|
Infant | 63 | 2025 | 12475 | 0.910 |
Why?
|
Catheters, Indwelling | 4 | 2021 | 154 | 0.890 |
Why?
|
Fetal Diseases | 8 | 2025 | 455 | 0.860 |
Why?
|
Pelvic Floor | 7 | 2014 | 34 | 0.860 |
Why?
|
Foreign-Body Migration | 2 | 2014 | 72 | 0.850 |
Why?
|
Medulloblastoma | 7 | 2024 | 325 | 0.850 |
Why?
|
Cervical Vertebrae | 10 | 2024 | 114 | 0.820 |
Why?
|
Adaptation, Psychological | 8 | 2024 | 445 | 0.810 |
Why?
|
Stress, Psychological | 5 | 2017 | 556 | 0.810 |
Why?
|
Prospective Studies | 35 | 2025 | 6147 | 0.790 |
Why?
|
Postoperative Complications | 21 | 2024 | 3071 | 0.790 |
Why?
|
Surveys and Questionnaires | 24 | 2023 | 3717 | 0.780 |
Why?
|
Cerebral Ventricles | 4 | 2024 | 80 | 0.770 |
Why?
|
Adult | 66 | 2024 | 29487 | 0.760 |
Why?
|
Adolescent | 68 | 2024 | 19287 | 0.740 |
Why?
|
Cerebral Hemorrhage | 7 | 2025 | 140 | 0.740 |
Why?
|
Pituitary Neoplasms | 4 | 2023 | 80 | 0.730 |
Why?
|
Echoencephalography | 2 | 2013 | 23 | 0.720 |
Why?
|
Reoperation | 15 | 2025 | 833 | 0.700 |
Why?
|
Practice Patterns, Physicians' | 3 | 2018 | 729 | 0.670 |
Why?
|
Severity of Illness Index | 19 | 2020 | 2895 | 0.670 |
Why?
|
Child Behavior | 3 | 2015 | 230 | 0.660 |
Why?
|
Fetus | 9 | 2024 | 585 | 0.660 |
Why?
|
Brain Neoplasms | 10 | 2024 | 1212 | 0.650 |
Why?
|
Cohort Studies | 30 | 2025 | 4802 | 0.640 |
Why?
|
Obstetric Labor Complications | 4 | 2018 | 93 | 0.620 |
Why?
|
Magnetic Resonance Imaging | 28 | 2024 | 3556 | 0.610 |
Why?
|
Urinary Incontinence | 10 | 2018 | 70 | 0.610 |
Why?
|
Gestational Age | 15 | 2024 | 1158 | 0.600 |
Why?
|
Chordoma | 3 | 2024 | 20 | 0.590 |
Why?
|
Syringomyelia | 3 | 2024 | 17 | 0.580 |
Why?
|
Catheters | 4 | 2023 | 87 | 0.570 |
Why?
|
Uterine Prolapse | 5 | 2008 | 19 | 0.570 |
Why?
|
Anesthesia, Closed-Circuit | 1 | 2017 | 2 | 0.570 |
Why?
|
Choroid Plexus | 5 | 2021 | 23 | 0.570 |
Why?
|
Bone Screws | 7 | 2011 | 51 | 0.560 |
Why?
|
Phenylephrine | 1 | 2017 | 38 | 0.560 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2017 | 49 | 0.540 |
Why?
|
Prevalence | 14 | 2021 | 2447 | 0.530 |
Why?
|
Risk Factors | 29 | 2022 | 10286 | 0.530 |
Why?
|
Vasoconstrictor Agents | 1 | 2017 | 136 | 0.530 |
Why?
|
Mother-Child Relations | 2 | 2015 | 77 | 0.510 |
Why?
|
Premature Birth | 5 | 2023 | 385 | 0.500 |
Why?
|
Endoscopy | 4 | 2019 | 280 | 0.500 |
Why?
|
Surgical Wound Infection | 5 | 2022 | 260 | 0.490 |
Why?
|
Dietary Fiber | 2 | 2013 | 74 | 0.480 |
Why?
|
Catheter Obstruction | 3 | 2024 | 8 | 0.460 |
Why?
|
Decompression, Surgical | 5 | 2024 | 98 | 0.460 |
Why?
|
Rectum | 6 | 2021 | 100 | 0.460 |
Why?
|
Delivery, Obstetric | 6 | 2021 | 251 | 0.460 |
Why?
|
Middle Aged | 38 | 2021 | 26797 | 0.460 |
Why?
|
Adolescent Behavior | 2 | 2015 | 168 | 0.450 |
Why?
|
Diarrhea | 2 | 2013 | 317 | 0.440 |
Why?
|
Decision Support Techniques | 1 | 2017 | 292 | 0.440 |
Why?
|
Child Development | 3 | 2025 | 267 | 0.430 |
Why?
|
Ependymoma | 3 | 2023 | 125 | 0.430 |
Why?
|
Water Deprivation | 1 | 2013 | 4 | 0.430 |
Why?
|
Skull Base Neoplasms | 2 | 2014 | 35 | 0.430 |
Why?
|
Drinking Behavior | 1 | 2013 | 8 | 0.420 |
Why?
|
Manometry | 7 | 2021 | 48 | 0.420 |
Why?
|
Prenatal Care | 5 | 2023 | 347 | 0.420 |
Why?
|
Pain Measurement | 8 | 2018 | 361 | 0.420 |
Why?
|
Young Adult | 24 | 2024 | 9025 | 0.420 |
Why?
|
Central Nervous System Cysts | 1 | 2012 | 11 | 0.410 |
Why?
|
Infant, Premature | 7 | 2025 | 812 | 0.410 |
Why?
|
Nasal Septum | 1 | 2012 | 17 | 0.410 |
Why?
|
Behavior Therapy | 4 | 2009 | 254 | 0.410 |
Why?
|
Surgery, Computer-Assisted | 2 | 2016 | 57 | 0.410 |
Why?
|
Sensation | 6 | 2021 | 58 | 0.400 |
Why?
|
Walking | 3 | 2024 | 212 | 0.400 |
Why?
|
Plant Extracts | 1 | 2014 | 120 | 0.400 |
Why?
|
Spinal Neoplasms | 4 | 2019 | 58 | 0.400 |
Why?
|
United States | 21 | 2019 | 10899 | 0.390 |
Why?
|
Referral and Consultation | 2 | 2019 | 541 | 0.380 |
Why?
|
Ultrasonography, Interventional | 1 | 2013 | 191 | 0.380 |
Why?
|
Multivariate Analysis | 9 | 2018 | 1435 | 0.380 |
Why?
|
Follow-Up Studies | 21 | 2024 | 5161 | 0.380 |
Why?
|
Blood Pressure | 1 | 2017 | 1351 | 0.380 |
Why?
|
Bacterial Infections | 4 | 2019 | 309 | 0.370 |
Why?
|
Kyphosis | 5 | 2012 | 22 | 0.370 |
Why?
|
Neuroimaging | 4 | 2020 | 335 | 0.370 |
Why?
|
Nurses | 3 | 2022 | 64 | 0.370 |
Why?
|
Defecation | 4 | 2017 | 30 | 0.370 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 1269 | 0.360 |
Why?
|
Sick Role | 3 | 2006 | 31 | 0.360 |
Why?
|
Urogenital Surgical Procedures | 2 | 2007 | 8 | 0.360 |
Why?
|
Radiotherapy, Intensity-Modulated | 3 | 2017 | 71 | 0.360 |
Why?
|
Aged | 32 | 2022 | 19764 | 0.360 |
Why?
|
Surgical Flaps | 1 | 2012 | 204 | 0.350 |
Why?
|
Age Factors | 13 | 2021 | 2820 | 0.350 |
Why?
|
Laparotomy | 4 | 2024 | 135 | 0.340 |
Why?
|
Odontoid Process | 2 | 2024 | 9 | 0.340 |
Why?
|
Rectal Diseases | 3 | 2007 | 18 | 0.330 |
Why?
|
Anti-Bacterial Agents | 8 | 2022 | 2428 | 0.330 |
Why?
|
Cerebrospinal Fluid | 3 | 2020 | 94 | 0.330 |
Why?
|
Parents | 4 | 2016 | 1015 | 0.320 |
Why?
|
Magnesium Sulfate | 2 | 2021 | 49 | 0.320 |
Why?
|
Nursing Homes | 1 | 2010 | 92 | 0.320 |
Why?
|
Neurodevelopmental Disorders | 2 | 2025 | 501 | 0.320 |
Why?
|
Urinary Bladder Diseases | 2 | 2021 | 35 | 0.320 |
Why?
|
Hypothermia | 2 | 2021 | 57 | 0.320 |
Why?
|
Scoliosis | 5 | 2022 | 135 | 0.320 |
Why?
|
Motor Activity | 3 | 2021 | 521 | 0.320 |
Why?
|
Craniopharyngioma | 2 | 2023 | 33 | 0.320 |
Why?
|
Geriatric Assessment | 1 | 2010 | 174 | 0.310 |
Why?
|
Clinical Decision-Making | 4 | 2019 | 266 | 0.310 |
Why?
|
Hydrothorax | 1 | 2008 | 11 | 0.310 |
Why?
|
Antidiarrheals | 3 | 2019 | 17 | 0.310 |
Why?
|
Atlanto-Occipital Joint | 2 | 2024 | 6 | 0.310 |
Why?
|
Anxiety | 5 | 2017 | 942 | 0.310 |
Why?
|
Tomography, X-Ray Computed | 16 | 2021 | 2092 | 0.310 |
Why?
|
Cervical Atlas | 2 | 2024 | 8 | 0.310 |
Why?
|
Research Design | 3 | 2016 | 693 | 0.310 |
Why?
|
Kaplan-Meier Estimate | 6 | 2020 | 1037 | 0.300 |
Why?
|
Spine | 5 | 2012 | 142 | 0.300 |
Why?
|
Rectocele | 2 | 2008 | 3 | 0.300 |
Why?
|
Neurosurgery | 3 | 2024 | 74 | 0.300 |
Why?
|
Brain | 7 | 2024 | 2982 | 0.290 |
Why?
|
Loperamide | 2 | 2019 | 8 | 0.290 |
Why?
|
Radiography | 13 | 2015 | 821 | 0.290 |
Why?
|
Electromyography | 6 | 2009 | 165 | 0.280 |
Why?
|
Lumbar Vertebrae | 4 | 2011 | 113 | 0.280 |
Why?
|
Feeding Behavior | 1 | 2013 | 701 | 0.280 |
Why?
|
Child Abuse | 1 | 2010 | 193 | 0.280 |
Why?
|
Global Health | 3 | 2021 | 560 | 0.270 |
Why?
|
Skull Base | 3 | 2024 | 53 | 0.270 |
Why?
|
Joint Instability | 4 | 2020 | 42 | 0.270 |
Why?
|
Epidermal Cyst | 1 | 2006 | 19 | 0.260 |
Why?
|
Pain Threshold | 3 | 2017 | 21 | 0.260 |
Why?
|
Catheterization | 1 | 2007 | 234 | 0.260 |
Why?
|
Parent-Child Relations | 4 | 2013 | 246 | 0.250 |
Why?
|
Atlanto-Axial Joint | 3 | 2012 | 20 | 0.250 |
Why?
|
Intestinal Obstruction | 1 | 2007 | 94 | 0.250 |
Why?
|
Longitudinal Studies | 8 | 2021 | 1328 | 0.250 |
Why?
|
Chi-Square Distribution | 3 | 2014 | 590 | 0.250 |
Why?
|
Infant, Premature, Diseases | 2 | 2021 | 242 | 0.250 |
Why?
|
Health Surveys | 6 | 2020 | 241 | 0.250 |
Why?
|
Cerebellar Diseases | 1 | 2006 | 73 | 0.250 |
Why?
|
Prosthesis-Related Infections | 3 | 2017 | 177 | 0.250 |
Why?
|
Carbon Dioxide | 4 | 2023 | 274 | 0.250 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 2156 | 0.240 |
Why?
|
Registries | 6 | 2025 | 1434 | 0.240 |
Why?
|
Ataxia | 1 | 2007 | 170 | 0.240 |
Why?
|
Logistic Models | 7 | 2012 | 1812 | 0.240 |
Why?
|
Ultrasonography, Prenatal | 5 | 2024 | 968 | 0.240 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2021 | 1111 | 0.240 |
Why?
|
Disability Evaluation | 4 | 2017 | 193 | 0.240 |
Why?
|
Craniosynostoses | 2 | 2021 | 133 | 0.240 |
Why?
|
Thoracic Vertebrae | 5 | 2012 | 68 | 0.230 |
Why?
|
Rhabdoid Tumor | 2 | 2018 | 47 | 0.230 |
Why?
|
Growth Disorders | 1 | 2006 | 209 | 0.230 |
Why?
|
Anesthesia, Obstetrical | 1 | 2024 | 33 | 0.230 |
Why?
|
Cerebrospinal Fluid Leak | 3 | 2021 | 43 | 0.230 |
Why?
|
Illness Behavior | 2 | 2015 | 7 | 0.230 |
Why?
|
Occipital Bone | 1 | 2024 | 21 | 0.220 |
Why?
|
Proportional Hazards Models | 6 | 2018 | 1356 | 0.220 |
Why?
|
Craniotomy | 4 | 2021 | 108 | 0.220 |
Why?
|
Linear Models | 5 | 2016 | 676 | 0.220 |
Why?
|
Body Mass Index | 3 | 2020 | 1563 | 0.220 |
Why?
|
Crohn Disease | 2 | 2017 | 283 | 0.220 |
Why?
|
Mutism | 1 | 2024 | 27 | 0.220 |
Why?
|
Sex Distribution | 4 | 2020 | 303 | 0.220 |
Why?
|
Guideline Adherence | 2 | 2017 | 382 | 0.220 |
Why?
|
Canada | 3 | 2019 | 288 | 0.220 |
Why?
|
Rome | 2 | 2023 | 7 | 0.220 |
Why?
|
Odds Ratio | 5 | 2018 | 1259 | 0.220 |
Why?
|
Heart Rate, Fetal | 2 | 2021 | 62 | 0.210 |
Why?
|
Bradycardia | 3 | 2021 | 61 | 0.210 |
Why?
|
Recurrence | 6 | 2023 | 1421 | 0.210 |
Why?
|
Anesthesia, General | 3 | 2024 | 118 | 0.210 |
Why?
|
Glioma | 2 | 2021 | 491 | 0.210 |
Why?
|
Time Factors | 10 | 2021 | 6308 | 0.200 |
Why?
|
Phaeohyphomycosis | 1 | 2022 | 10 | 0.200 |
Why?
|
Reproducibility of Results | 4 | 2017 | 2878 | 0.200 |
Why?
|
Depression | 7 | 2017 | 1224 | 0.200 |
Why?
|
Cerebral Ventriculitis | 1 | 2022 | 15 | 0.200 |
Why?
|
Cysts | 1 | 2023 | 101 | 0.200 |
Why?
|
Central Nervous System Infections | 1 | 2022 | 21 | 0.200 |
Why?
|
Pain | 3 | 2017 | 461 | 0.200 |
Why?
|
Analysis of Variance | 5 | 2015 | 1016 | 0.200 |
Why?
|
Patient Acceptance of Health Care | 2 | 2008 | 422 | 0.200 |
Why?
|
Amnion | 2 | 2020 | 38 | 0.200 |
Why?
|
Clinical Protocols | 2 | 2015 | 240 | 0.200 |
Why?
|
Cerebellar Vermis | 1 | 2022 | 4 | 0.200 |
Why?
|
Cranial Sutures | 2 | 2012 | 32 | 0.200 |
Why?
|
Intelligence | 2 | 2019 | 98 | 0.200 |
Why?
|
Corpus Callosum | 1 | 2022 | 95 | 0.200 |
Why?
|
Pregnancy Outcome | 3 | 2020 | 588 | 0.200 |
Why?
|
United Kingdom | 2 | 2020 | 189 | 0.200 |
Why?
|
Symptom Assessment | 3 | 2017 | 100 | 0.200 |
Why?
|
Transition to Adult Care | 1 | 2024 | 119 | 0.190 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2021 | 1688 | 0.190 |
Why?
|
Nervous System Malformations | 1 | 2023 | 130 | 0.190 |
Why?
|
Survivorship | 1 | 2022 | 36 | 0.190 |
Why?
|
Craniospinal Irradiation | 2 | 2019 | 58 | 0.190 |
Why?
|
Cost-Benefit Analysis | 2 | 2021 | 509 | 0.190 |
Why?
|
Machine Learning | 1 | 2024 | 250 | 0.190 |
Why?
|
Ultrasonography | 3 | 2016 | 929 | 0.190 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2016 | 304 | 0.190 |
Why?
|
Anus Diseases | 3 | 2007 | 12 | 0.190 |
Why?
|
Transferrin | 1 | 2021 | 49 | 0.190 |
Why?
|
Astrocytoma | 3 | 2013 | 99 | 0.190 |
Why?
|
Cerebrospinal Fluid Otorrhea | 1 | 2021 | 5 | 0.180 |
Why?
|
Mechanical Thrombolysis | 1 | 2021 | 11 | 0.180 |
Why?
|
Constriction, Pathologic | 2 | 2020 | 242 | 0.180 |
Why?
|
CD56 Antigen | 1 | 2021 | 26 | 0.180 |
Why?
|
Tympanic Membrane | 1 | 2021 | 18 | 0.180 |
Why?
|
Prognosis | 6 | 2024 | 4627 | 0.180 |
Why?
|
Incidence | 7 | 2020 | 3142 | 0.180 |
Why?
|
Rhombencephalon | 1 | 2021 | 46 | 0.180 |
Why?
|
Dura Mater | 1 | 2021 | 25 | 0.180 |
Why?
|
Ear, Inner | 1 | 2021 | 49 | 0.180 |
Why?
|
Ferritins | 1 | 2021 | 97 | 0.180 |
Why?
|
Fistula | 1 | 2021 | 49 | 0.180 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2021 | 48 | 0.180 |
Why?
|
Clinical Competence | 3 | 2018 | 999 | 0.180 |
Why?
|
Cranial Fontanelles | 2 | 2012 | 4 | 0.180 |
Why?
|
Gadolinium | 1 | 2021 | 106 | 0.180 |
Why?
|
Wound Closure Techniques | 1 | 2020 | 23 | 0.170 |
Why?
|
Postural Orthostatic Tachycardia Syndrome | 1 | 2020 | 11 | 0.170 |
Why?
|
White Matter | 1 | 2022 | 178 | 0.170 |
Why?
|
Healthcare Disparities | 1 | 2025 | 431 | 0.170 |
Why?
|
Neurosurgeons | 1 | 2020 | 12 | 0.170 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 51 | 0.170 |
Why?
|
alpha-Fetoproteins | 1 | 2021 | 132 | 0.170 |
Why?
|
Mycobacterium abscessus | 1 | 2020 | 6 | 0.170 |
Why?
|
Indomethacin | 1 | 2020 | 84 | 0.170 |
Why?
|
Ehlers-Danlos Syndrome | 1 | 2020 | 46 | 0.170 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2020 | 64 | 0.170 |
Why?
|
Infratentorial Neoplasms | 2 | 2010 | 30 | 0.170 |
Why?
|
Fetal Membranes, Premature Rupture | 1 | 2020 | 61 | 0.170 |
Why?
|
Biomarkers, Tumor | 3 | 2018 | 1484 | 0.170 |
Why?
|
Microsurgery | 2 | 2011 | 68 | 0.160 |
Why?
|
Mycobacterium Infections, Nontuberculous | 1 | 2020 | 46 | 0.160 |
Why?
|
Ductus Arteriosus | 1 | 2020 | 62 | 0.160 |
Why?
|
Photons | 1 | 2019 | 48 | 0.160 |
Why?
|
Debridement | 1 | 2020 | 89 | 0.160 |
Why?
|
Fibrinolytic Agents | 1 | 2021 | 203 | 0.160 |
Why?
|
Surgical Wound Dehiscence | 1 | 2019 | 51 | 0.160 |
Why?
|
Vagina | 2 | 2009 | 194 | 0.160 |
Why?
|
Hernia | 1 | 2019 | 19 | 0.160 |
Why?
|
Aged, 80 and over | 9 | 2018 | 6548 | 0.160 |
Why?
|
Gastroenterology | 1 | 2002 | 196 | 0.160 |
Why?
|
Episiotomy | 4 | 2013 | 16 | 0.160 |
Why?
|
SMARCB1 Protein | 1 | 2018 | 38 | 0.150 |
Why?
|
Hematoma, Subdural | 1 | 2018 | 20 | 0.150 |
Why?
|
Fetal Weight | 1 | 2019 | 61 | 0.150 |
Why?
|
Intracranial Arteriovenous Malformations | 2 | 2009 | 30 | 0.150 |
Why?
|
Equipment Design | 3 | 2016 | 596 | 0.150 |
Why?
|
Movement Disorders | 1 | 2021 | 222 | 0.150 |
Why?
|
Placenta Diseases | 1 | 2019 | 59 | 0.150 |
Why?
|
Umbilical Arteries | 1 | 2019 | 95 | 0.150 |
Why?
|
Embolization, Therapeutic | 2 | 2012 | 222 | 0.150 |
Why?
|
Amniotic Fluid | 1 | 2019 | 150 | 0.150 |
Why?
|
Primary Health Care | 2 | 2018 | 771 | 0.150 |
Why?
|
Meningocele | 1 | 2018 | 19 | 0.150 |
Why?
|
Placenta | 2 | 2020 | 506 | 0.150 |
Why?
|
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.) | 2 | 2014 | 8 | 0.150 |
Why?
|
Health Care Costs | 3 | 2011 | 371 | 0.150 |
Why?
|
Memory, Short-Term | 1 | 2019 | 140 | 0.150 |
Why?
|
Ultrasonography, Doppler | 1 | 2019 | 195 | 0.140 |
Why?
|
Sex Factors | 5 | 2017 | 1287 | 0.140 |
Why?
|
Protons | 3 | 2023 | 92 | 0.140 |
Why?
|
Texas | 6 | 2024 | 3586 | 0.140 |
Why?
|
Teratoma | 1 | 2018 | 121 | 0.140 |
Why?
|
Fetal Development | 1 | 2019 | 132 | 0.140 |
Why?
|
Nitroprusside | 1 | 2017 | 47 | 0.140 |
Why?
|
Computers | 1 | 2017 | 68 | 0.140 |
Why?
|
Prenatal Diagnosis | 4 | 2023 | 597 | 0.140 |
Why?
|
Patient Admission | 1 | 2018 | 186 | 0.140 |
Why?
|
Automation | 1 | 2017 | 63 | 0.140 |
Why?
|
Ambulatory Care | 3 | 2011 | 387 | 0.140 |
Why?
|
Intracranial Hemorrhages | 2 | 2020 | 75 | 0.140 |
Why?
|
Age Distribution | 3 | 2020 | 415 | 0.140 |
Why?
|
Puerperal Disorders | 2 | 2007 | 45 | 0.140 |
Why?
|
Colon, Descending | 1 | 2017 | 3 | 0.140 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 1140 | 0.140 |
Why?
|
Gastric Fundus | 1 | 2017 | 9 | 0.140 |
Why?
|
Insufflation | 1 | 2017 | 20 | 0.140 |
Why?
|
Pleural Effusion | 2 | 2015 | 101 | 0.140 |
Why?
|
Cognition Disorders | 2 | 2019 | 553 | 0.140 |
Why?
|
Diagnostic Self Evaluation | 1 | 2017 | 21 | 0.140 |
Why?
|
Length of Stay | 6 | 2024 | 1312 | 0.140 |
Why?
|
Estrogen Replacement Therapy | 1 | 2017 | 44 | 0.140 |
Why?
|
Sensitivity and Specificity | 5 | 2021 | 2050 | 0.140 |
Why?
|
Fetal Therapies | 3 | 2025 | 80 | 0.130 |
Why?
|
Urinary Bladder | 2 | 2017 | 245 | 0.130 |
Why?
|
Cross-Sectional Studies | 6 | 2020 | 3432 | 0.130 |
Why?
|
Postmenopause | 1 | 2017 | 126 | 0.130 |
Why?
|
Vasodilation | 1 | 2017 | 190 | 0.130 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2018 | 223 | 0.130 |
Why?
|
Cross-Over Studies | 1 | 2017 | 313 | 0.130 |
Why?
|
Critical Pathways | 2 | 2010 | 76 | 0.130 |
Why?
|
Emergency Medical Services | 2 | 2011 | 437 | 0.130 |
Why?
|
Arm Injuries | 1 | 2015 | 13 | 0.130 |
Why?
|
Dyspepsia | 1 | 2017 | 100 | 0.130 |
Why?
|
Brain Concussion | 1 | 2018 | 229 | 0.130 |
Why?
|
Patient Education as Topic | 4 | 2019 | 441 | 0.120 |
Why?
|
Psyllium | 1 | 2015 | 11 | 0.120 |
Why?
|
Anesthesiology | 1 | 2017 | 94 | 0.120 |
Why?
|
Quality Improvement | 3 | 2022 | 640 | 0.120 |
Why?
|
Hypotension | 1 | 2017 | 185 | 0.120 |
Why?
|
Simulation Training | 1 | 2018 | 140 | 0.120 |
Why?
|
Intergenerational Relations | 1 | 2015 | 8 | 0.120 |
Why?
|
Cost of Illness | 2 | 2015 | 249 | 0.120 |
Why?
|
Emotions | 2 | 2024 | 352 | 0.120 |
Why?
|
Evidence-Based Medicine | 2 | 2017 | 634 | 0.120 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2012 | 580 | 0.120 |
Why?
|
Washington | 2 | 2016 | 32 | 0.120 |
Why?
|
Comorbidity | 6 | 2022 | 1532 | 0.120 |
Why?
|
Catastrophization | 1 | 2014 | 14 | 0.120 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 369 | 0.120 |
Why?
|
Antigens, CD1d | 1 | 2014 | 21 | 0.120 |
Why?
|
Cautery | 1 | 2014 | 6 | 0.120 |
Why?
|
Multicenter Studies as Topic | 3 | 2023 | 275 | 0.120 |
Why?
|
Checklist | 1 | 2015 | 85 | 0.110 |
Why?
|
Algorithms | 3 | 2017 | 1622 | 0.110 |
Why?
|
Encopresis | 1 | 1994 | 1 | 0.110 |
Why?
|
Gastrointestinal Transit | 1 | 2014 | 21 | 0.110 |
Why?
|
Models, Psychological | 1 | 2015 | 138 | 0.110 |
Why?
|
Colonic Diseases, Functional | 2 | 2007 | 14 | 0.110 |
Why?
|
Skull Neoplasms | 1 | 2014 | 14 | 0.110 |
Why?
|
Catheter-Related Infections | 1 | 2015 | 128 | 0.110 |
Why?
|
Placebo Effect | 1 | 2014 | 25 | 0.110 |
Why?
|
North Carolina | 1 | 2014 | 59 | 0.110 |
Why?
|
Swine | 1 | 2017 | 1177 | 0.110 |
Why?
|
Cerebral Cortex | 2 | 2014 | 451 | 0.110 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2014 | 87 | 0.110 |
Why?
|
Sample Size | 1 | 2013 | 86 | 0.110 |
Why?
|
Thoracic Surgery, Video-Assisted | 2 | 2011 | 56 | 0.110 |
Why?
|
Survivors | 3 | 2022 | 336 | 0.110 |
Why?
|
Double-Blind Method | 2 | 2015 | 1640 | 0.110 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2013 | 31 | 0.110 |
Why?
|
Natural Killer T-Cells | 1 | 2014 | 82 | 0.110 |
Why?
|
Activities of Daily Living | 1 | 2015 | 402 | 0.100 |
Why?
|
Disease-Free Survival | 4 | 2017 | 873 | 0.100 |
Why?
|
Malaysia | 1 | 2012 | 13 | 0.100 |
Why?
|
Internal Fixators | 1 | 2012 | 12 | 0.100 |
Why?
|
Endovascular Procedures | 1 | 2021 | 738 | 0.100 |
Why?
|
Statistics, Nonparametric | 4 | 2021 | 429 | 0.100 |
Why?
|
Arthrodesis | 1 | 2012 | 14 | 0.100 |
Why?
|
Fasting | 1 | 2014 | 295 | 0.100 |
Why?
|
Exercise | 1 | 2018 | 817 | 0.100 |
Why?
|
Mass Screening | 1 | 2018 | 782 | 0.100 |
Why?
|
Aneurysm, Ruptured | 1 | 2012 | 35 | 0.100 |
Why?
|
Tretinoin | 2 | 2003 | 116 | 0.100 |
Why?
|
Tuberculosis, Spinal | 1 | 2012 | 8 | 0.100 |
Why?
|
Spinal Diseases | 1 | 2012 | 45 | 0.100 |
Why?
|
Neoplastic Stem Cells | 1 | 2014 | 290 | 0.100 |
Why?
|
Trichomonas Vaginitis | 1 | 1992 | 13 | 0.100 |
Why?
|
Hedgehog Proteins | 1 | 2013 | 185 | 0.100 |
Why?
|
Germ-Line Mutation | 1 | 2014 | 332 | 0.100 |
Why?
|
Health Maintenance Organizations | 2 | 2010 | 22 | 0.100 |
Why?
|
Sympathectomy | 1 | 2011 | 7 | 0.100 |
Why?
|
Educational Status | 1 | 2013 | 276 | 0.100 |
Why?
|
Osteoblastoma | 1 | 2011 | 3 | 0.100 |
Why?
|
Nervous System Diseases | 2 | 2013 | 375 | 0.100 |
Why?
|
Biomarkers | 1 | 2021 | 3067 | 0.100 |
Why?
|
Staphylococcus aureus | 3 | 2019 | 460 | 0.100 |
Why?
|
Posters as Topic | 1 | 2011 | 4 | 0.090 |
Why?
|
Intracranial Aneurysm | 1 | 2012 | 88 | 0.090 |
Why?
|
Postpartum Period | 3 | 2007 | 214 | 0.090 |
Why?
|
Drug Administration Schedule | 4 | 2015 | 721 | 0.090 |
Why?
|
Amenorrhea | 1 | 2011 | 20 | 0.090 |
Why?
|
Health Care Surveys | 1 | 2012 | 287 | 0.090 |
Why?
|
Cauda Equina | 1 | 2011 | 9 | 0.090 |
Why?
|
Self-Help Groups | 1 | 2011 | 17 | 0.090 |
Why?
|
Publications | 1 | 2011 | 33 | 0.090 |
Why?
|
Thoracoscopy | 1 | 2011 | 43 | 0.090 |
Why?
|
Diskectomy | 1 | 2011 | 12 | 0.090 |
Why?
|
Nutrition Surveys | 1 | 2013 | 293 | 0.090 |
Why?
|
Urinary Incontinence, Stress | 3 | 2007 | 31 | 0.090 |
Why?
|
Intervertebral Disc Displacement | 1 | 2011 | 19 | 0.090 |
Why?
|
Metronidazole | 1 | 1992 | 154 | 0.090 |
Why?
|
Fracture Fixation | 1 | 2011 | 25 | 0.090 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2013 | 209 | 0.090 |
Why?
|
Peer Review, Research | 1 | 2011 | 47 | 0.090 |
Why?
|
Skull | 2 | 2012 | 142 | 0.090 |
Why?
|
Intelligence Tests | 2 | 2022 | 57 | 0.090 |
Why?
|
Device Removal | 2 | 2018 | 221 | 0.090 |
Why?
|
Osteosarcoma | 1 | 2014 | 253 | 0.090 |
Why?
|
Evoked Potentials, Motor | 1 | 2011 | 33 | 0.090 |
Why?
|
Heart Diseases | 1 | 2015 | 491 | 0.090 |
Why?
|
Interviews as Topic | 2 | 2010 | 374 | 0.090 |
Why?
|
Hypertensive Encephalopathy | 1 | 2010 | 5 | 0.090 |
Why?
|
Cesarean Section | 4 | 2019 | 387 | 0.090 |
Why?
|
Long QT Syndrome | 1 | 2011 | 85 | 0.090 |
Why?
|
Recovery of Function | 2 | 2010 | 443 | 0.090 |
Why?
|
Physicians | 1 | 2017 | 581 | 0.090 |
Why?
|
Sutures | 1 | 2011 | 65 | 0.090 |
Why?
|
Vein of Galen Malformations | 1 | 2010 | 7 | 0.090 |
Why?
|
Probability | 2 | 2009 | 320 | 0.090 |
Why?
|
Hospitalization | 3 | 2024 | 1779 | 0.090 |
Why?
|
Geriatric Nursing | 1 | 2010 | 4 | 0.090 |
Why?
|
Macrophages | 1 | 2014 | 619 | 0.090 |
Why?
|
Monitoring, Intraoperative | 1 | 2011 | 128 | 0.090 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2010 | 23 | 0.090 |
Why?
|
Staphylococcal Infections | 3 | 2019 | 559 | 0.090 |
Why?
|
Congresses as Topic | 1 | 2011 | 173 | 0.090 |
Why?
|
Subarachnoid Space | 1 | 2010 | 24 | 0.090 |
Why?
|
Respiratory Tract Fistula | 1 | 2010 | 16 | 0.090 |
Why?
|
Organ Size | 2 | 2021 | 425 | 0.090 |
Why?
|
Polyesters | 1 | 2010 | 39 | 0.080 |
Why?
|
Pleural Diseases | 1 | 2010 | 28 | 0.080 |
Why?
|
Suicide, Attempted | 1 | 2011 | 128 | 0.080 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2011 | 125 | 0.080 |
Why?
|
Chronic Disease | 3 | 2011 | 1189 | 0.080 |
Why?
|
Pregnancy Trimester, Second | 2 | 2021 | 165 | 0.080 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2023 | 144 | 0.080 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2010 | 126 | 0.080 |
Why?
|
Neuropsychological Tests | 2 | 2024 | 924 | 0.080 |
Why?
|
Lacerations | 2 | 2007 | 34 | 0.080 |
Why?
|
Prosthesis Failure | 1 | 2010 | 158 | 0.080 |
Why?
|
Pressure | 3 | 2021 | 128 | 0.080 |
Why?
|
Pelvic Organ Prolapse | 1 | 2009 | 27 | 0.080 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2003 | 237 | 0.080 |
Why?
|
Hematoma, Epidural, Spinal | 1 | 2009 | 7 | 0.080 |
Why?
|
Gastrointestinal Agents | 1 | 2010 | 60 | 0.080 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2009 | 23 | 0.080 |
Why?
|
Neuroendoscopes | 1 | 2009 | 2 | 0.080 |
Why?
|
Intraoperative Complications | 1 | 2010 | 172 | 0.080 |
Why?
|
Thoracotomy | 1 | 2010 | 111 | 0.080 |
Why?
|
Case-Control Studies | 6 | 2019 | 3284 | 0.080 |
Why?
|
Laminectomy | 1 | 2009 | 26 | 0.080 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2015 | 848 | 0.080 |
Why?
|
Heart Defects, Congenital | 1 | 2021 | 1815 | 0.080 |
Why?
|
Chondroma | 1 | 2009 | 6 | 0.080 |
Why?
|
Social Environment | 1 | 2009 | 120 | 0.080 |
Why?
|
Postoperative Period | 2 | 2020 | 334 | 0.080 |
Why?
|
Patient Selection | 2 | 2014 | 695 | 0.080 |
Why?
|
Electric Stimulation Therapy | 1 | 2010 | 103 | 0.080 |
Why?
|
Ophthalmoplegia | 1 | 2009 | 54 | 0.080 |
Why?
|
Radiotherapy Dosage | 2 | 2023 | 183 | 0.080 |
Why?
|
Arteriovenous Malformations | 1 | 2009 | 47 | 0.080 |
Why?
|
Psychometrics | 1 | 2012 | 671 | 0.080 |
Why?
|
Risk Reduction Behavior | 1 | 2010 | 142 | 0.080 |
Why?
|
Fasciitis | 1 | 2008 | 20 | 0.080 |
Why?
|
Suicidal Ideation | 1 | 2011 | 215 | 0.080 |
Why?
|
Joint Dislocations | 1 | 2008 | 23 | 0.080 |
Why?
|
Confidence Intervals | 1 | 2009 | 285 | 0.080 |
Why?
|
Spinal Cord Neoplasms | 1 | 2009 | 71 | 0.080 |
Why?
|
Periosteum | 1 | 2009 | 33 | 0.080 |
Why?
|
Carotid Artery Injuries | 1 | 2008 | 40 | 0.070 |
Why?
|
Spinal Puncture | 1 | 2008 | 49 | 0.070 |
Why?
|
Occipital Lobe | 1 | 2008 | 32 | 0.070 |
Why?
|
Oxygen | 1 | 1992 | 553 | 0.070 |
Why?
|
Cognition | 2 | 2023 | 722 | 0.070 |
Why?
|
Radiography, Thoracic | 1 | 2008 | 152 | 0.070 |
Why?
|
Transforming Growth Factor beta | 1 | 2010 | 457 | 0.070 |
Why?
|
Pneumothorax | 1 | 2008 | 77 | 0.070 |
Why?
|
Labor, Obstetric | 2 | 2018 | 94 | 0.070 |
Why?
|
Infant, Very Low Birth Weight | 1 | 2009 | 171 | 0.070 |
Why?
|
Sweden | 2 | 2018 | 34 | 0.070 |
Why?
|
Ileus | 1 | 2007 | 9 | 0.070 |
Why?
|
Sacrum | 1 | 2007 | 29 | 0.070 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2003 | 668 | 0.070 |
Why?
|
Desipramine | 1 | 2007 | 27 | 0.070 |
Why?
|
Diazepam | 1 | 2007 | 21 | 0.070 |
Why?
|
Learning Curve | 2 | 2020 | 53 | 0.070 |
Why?
|
Adrenergic Uptake Inhibitors | 1 | 2007 | 27 | 0.070 |
Why?
|
Muscle Relaxants, Central | 1 | 2007 | 32 | 0.070 |
Why?
|
Muscle Weakness | 2 | 2013 | 84 | 0.070 |
Why?
|
Recombinant Proteins | 1 | 2010 | 1390 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 1214 | 0.070 |
Why?
|
Psychotherapy | 1 | 2009 | 229 | 0.070 |
Why?
|
Patient Satisfaction | 2 | 2008 | 475 | 0.070 |
Why?
|
Imaging, Three-Dimensional | 3 | 2021 | 370 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2013 | 1090 | 0.070 |
Why?
|
Radiation Injuries | 2 | 2019 | 142 | 0.060 |
Why?
|
Colonic Diseases | 1 | 2006 | 38 | 0.060 |
Why?
|
DNA-Binding Proteins | 3 | 2003 | 2043 | 0.060 |
Why?
|
Gynecologic Surgical Procedures | 1 | 2006 | 63 | 0.060 |
Why?
|
Glasgow Coma Scale | 2 | 2018 | 207 | 0.060 |
Why?
|
Reference Values | 2 | 2021 | 711 | 0.060 |
Why?
|
North America | 2 | 2017 | 240 | 0.060 |
Why?
|
Nose Neoplasms | 1 | 2005 | 32 | 0.060 |
Why?
|
Osteotomy | 1 | 2005 | 38 | 0.060 |
Why?
|
Drainage | 2 | 2018 | 258 | 0.060 |
Why?
|
Dilatation | 2 | 2017 | 64 | 0.060 |
Why?
|
Patient Positioning | 2 | 2018 | 54 | 0.060 |
Why?
|
Self Report | 2 | 2018 | 513 | 0.060 |
Why?
|
Dermoid Cyst | 1 | 2005 | 34 | 0.060 |
Why?
|
Pinealoma | 1 | 2024 | 19 | 0.060 |
Why?
|
Family Health | 1 | 2004 | 259 | 0.050 |
Why?
|
Child Health Services | 1 | 2004 | 86 | 0.050 |
Why?
|
Phosphoproteins | 2 | 2003 | 401 | 0.050 |
Why?
|
Heart-Assist Devices | 1 | 2012 | 1021 | 0.050 |
Why?
|
Abdomen | 2 | 2023 | 127 | 0.050 |
Why?
|
Sex Offenses | 1 | 2004 | 48 | 0.050 |
Why?
|
Combined Modality Therapy | 2 | 2010 | 1233 | 0.050 |
Why?
|
Antineoplastic Agents | 2 | 2003 | 1662 | 0.050 |
Why?
|
Turkey | 1 | 2023 | 59 | 0.050 |
Why?
|
Muscle, Smooth | 1 | 2003 | 135 | 0.050 |
Why?
|
Societies, Medical | 2 | 2021 | 693 | 0.050 |
Why?
|
Self Care | 2 | 2015 | 215 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2011 | 1116 | 0.050 |
Why?
|
Population Surveillance | 1 | 2005 | 388 | 0.050 |
Why?
|
Ascomycota | 1 | 2022 | 24 | 0.050 |
Why?
|
Health Status | 1 | 2004 | 375 | 0.050 |
Why?
|
Verbal Learning | 1 | 2022 | 66 | 0.050 |
Why?
|
Cervix Uteri | 1 | 2023 | 64 | 0.050 |
Why?
|
Microarray Analysis | 1 | 2023 | 229 | 0.050 |
Why?
|
Cyclins | 1 | 2003 | 101 | 0.050 |
Why?
|
Japan | 2 | 2014 | 133 | 0.050 |
Why?
|
China | 1 | 2023 | 243 | 0.050 |
Why?
|
Papillomaviridae | 1 | 2003 | 143 | 0.050 |
Why?
|
Amphotericin B | 1 | 2022 | 90 | 0.050 |
Why?
|
Uterus | 2 | 2019 | 569 | 0.050 |
Why?
|
Cranial Fossa, Posterior | 1 | 2022 | 14 | 0.050 |
Why?
|
Safety | 2 | 2014 | 219 | 0.050 |
Why?
|
Physician-Patient Relations | 1 | 2006 | 429 | 0.050 |
Why?
|
Gram-Negative Facultatively Anaerobic Rods | 1 | 2001 | 1 | 0.050 |
Why?
|
DNA, Viral | 2 | 2003 | 480 | 0.050 |
Why?
|
Heart Atria | 1 | 2024 | 316 | 0.050 |
Why?
|
Fetal Movement | 1 | 2021 | 14 | 0.050 |
Why?
|
Cesarean Section, Repeat | 1 | 2021 | 8 | 0.050 |
Why?
|
Enhancer Elements, Genetic | 1 | 2003 | 294 | 0.050 |
Why?
|
Obesity | 1 | 2013 | 2245 | 0.050 |
Why?
|
Rewarming | 1 | 2021 | 12 | 0.050 |
Why?
|
Staphylococcus epidermidis | 1 | 2001 | 39 | 0.050 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 2021 | 23 | 0.050 |
Why?
|
Clubfoot | 1 | 2021 | 19 | 0.050 |
Why?
|
Neural Cell Adhesion Molecule L1 | 1 | 2021 | 6 | 0.050 |
Why?
|
Mastoidectomy | 1 | 2021 | 6 | 0.050 |
Why?
|
Viral Proteins | 1 | 2003 | 347 | 0.050 |
Why?
|
Surgical Instruments | 1 | 2021 | 55 | 0.050 |
Why?
|
Slit Ventricle Syndrome | 1 | 2020 | 1 | 0.050 |
Why?
|
Prolactinoma | 1 | 2001 | 4 | 0.050 |
Why?
|
Labor, Induced | 1 | 2021 | 34 | 0.050 |
Why?
|
Encephalocele | 1 | 2021 | 51 | 0.040 |
Why?
|
Central Nervous System | 1 | 2022 | 253 | 0.040 |
Why?
|
Diffusion Tensor Imaging | 1 | 2022 | 235 | 0.040 |
Why?
|
Hospital Charges | 1 | 2021 | 61 | 0.040 |
Why?
|
Nausea | 1 | 2001 | 84 | 0.040 |
Why?
|
Transplants | 1 | 2021 | 35 | 0.040 |
Why?
|
Mutation | 1 | 2014 | 5825 | 0.040 |
Why?
|
Preoperative Period | 1 | 2020 | 89 | 0.040 |
Why?
|
Healthy Volunteers | 1 | 2021 | 134 | 0.040 |
Why?
|
Temperature | 1 | 2021 | 303 | 0.040 |
Why?
|
Transplantation, Heterologous | 1 | 2021 | 254 | 0.040 |
Why?
|
Respiratory Distress Syndrome, Newborn | 1 | 2021 | 79 | 0.040 |
Why?
|
Abortion, Spontaneous | 1 | 2021 | 79 | 0.040 |
Why?
|
Transplantation, Autologous | 1 | 2021 | 298 | 0.040 |
Why?
|
Headache | 1 | 2001 | 107 | 0.040 |
Why?
|
Vomiting | 1 | 2001 | 105 | 0.040 |
Why?
|
Vancomycin | 1 | 2022 | 219 | 0.040 |
Why?
|
Antifungal Agents | 1 | 2022 | 288 | 0.040 |
Why?
|
Uterine Contraction | 1 | 2019 | 28 | 0.040 |
Why?
|
Pulsatile Flow | 1 | 2020 | 128 | 0.040 |
Why?
|
Data Collection | 1 | 2001 | 381 | 0.040 |
Why?
|
Propionibacterium acnes | 1 | 2019 | 12 | 0.040 |
Why?
|
Hepatitis B Core Antigens | 1 | 1999 | 15 | 0.040 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2020 | 63 | 0.040 |
Why?
|
Codon | 1 | 1999 | 97 | 0.040 |
Why?
|
Animals | 3 | 2017 | 34023 | 0.040 |
Why?
|
Virus Assembly | 1 | 1999 | 47 | 0.040 |
Why?
|
DNA, Single-Stranded | 1 | 1999 | 74 | 0.040 |
Why?
|
Risk | 1 | 2021 | 755 | 0.040 |
Why?
|
Intraoperative Period | 1 | 2019 | 74 | 0.040 |
Why?
|
Umbilical Veins | 1 | 2019 | 73 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2021 | 311 | 0.040 |
Why?
|
Remission, Spontaneous | 1 | 2018 | 69 | 0.040 |
Why?
|
Perioperative Care | 1 | 2021 | 195 | 0.040 |
Why?
|
Postnatal Care | 1 | 2019 | 51 | 0.040 |
Why?
|
Iron | 1 | 2021 | 266 | 0.040 |
Why?
|
Workflow | 1 | 2019 | 118 | 0.040 |
Why?
|
Ribs | 1 | 2019 | 52 | 0.040 |
Why?
|
Portal Vein | 1 | 2019 | 94 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 1 | 2001 | 795 | 0.040 |
Why?
|
Electronic Mail | 1 | 2018 | 40 | 0.040 |
Why?
|
Heart Rate | 1 | 2021 | 590 | 0.040 |
Why?
|
Hepatitis B virus | 1 | 1999 | 130 | 0.040 |
Why?
|
Trial of Labor | 1 | 2018 | 21 | 0.040 |
Why?
|
Oxytocics | 1 | 2018 | 28 | 0.040 |
Why?
|
Health Education | 1 | 2020 | 221 | 0.040 |
Why?
|
Iatrogenic Disease | 1 | 2019 | 133 | 0.040 |
Why?
|
Cold Temperature | 1 | 2018 | 77 | 0.040 |
Why?
|
Urodynamics | 1 | 2017 | 40 | 0.040 |
Why?
|
Meningitis | 1 | 2018 | 99 | 0.040 |
Why?
|
Oxytocin | 1 | 2018 | 68 | 0.040 |
Why?
|
Contrast Media | 1 | 2021 | 473 | 0.040 |
Why?
|
Sickness Impact Profile | 2 | 2007 | 36 | 0.040 |
Why?
|
Spinal Cord | 2 | 2009 | 300 | 0.030 |
Why?
|
Program Evaluation | 1 | 2019 | 444 | 0.030 |
Why?
|
Magnetic Resonance Angiography | 2 | 2012 | 163 | 0.030 |
Why?
|
Birth Weight | 1 | 2019 | 346 | 0.030 |
Why?
|
Models, Anatomic | 1 | 2018 | 99 | 0.030 |
Why?
|
Parity | 2 | 2007 | 78 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2017 | 68 | 0.030 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 416 | 0.030 |
Why?
|
Maternal Exposure | 1 | 2018 | 148 | 0.030 |
Why?
|
Infant, Low Birth Weight | 1 | 2017 | 167 | 0.030 |
Why?
|
Visual Acuity | 1 | 2001 | 817 | 0.030 |
Why?
|
Databases, Factual | 1 | 2021 | 1178 | 0.030 |
Why?
|
Cathartics | 1 | 2015 | 27 | 0.030 |
Why?
|
Social Isolation | 1 | 2015 | 41 | 0.030 |
Why?
|
Biopsy | 2 | 2009 | 1237 | 0.030 |
Why?
|
Arm | 1 | 2015 | 81 | 0.030 |
Why?
|
Diet | 1 | 2022 | 1137 | 0.030 |
Why?
|
Mothers | 1 | 2018 | 353 | 0.030 |
Why?
|
Computer Simulation | 1 | 2018 | 646 | 0.030 |
Why?
|
Cerebral Aqueduct | 1 | 2014 | 10 | 0.030 |
Why?
|
Mutation, Missense | 1 | 1999 | 875 | 0.030 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2018 | 481 | 0.030 |
Why?
|
Echocardiography | 1 | 2020 | 1052 | 0.030 |
Why?
|
Pain Management | 1 | 2016 | 181 | 0.030 |
Why?
|
Brain Stem | 1 | 2015 | 115 | 0.030 |
Why?
|
Disease Management | 1 | 2018 | 524 | 0.030 |
Why?
|
Oncogene Protein v-akt | 1 | 2014 | 30 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2011 | 760 | 0.030 |
Why?
|
Drinking Water | 1 | 2014 | 14 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2014 | 53 | 0.030 |
Why?
|
Education | 1 | 2014 | 109 | 0.030 |
Why?
|
Drinking | 1 | 2014 | 34 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2014 | 258 | 0.030 |
Why?
|
Aging | 1 | 2021 | 1182 | 0.030 |
Why?
|
Poaceae | 1 | 1993 | 12 | 0.030 |
Why?
|
Animal Feed | 1 | 1993 | 79 | 0.030 |
Why?
|
ras Proteins | 1 | 2014 | 137 | 0.030 |
Why?
|
Paresis | 1 | 2013 | 35 | 0.030 |
Why?
|
Social Support | 1 | 2015 | 345 | 0.030 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2016 | 806 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2014 | 2814 | 0.030 |
Why?
|
Transcription Factors | 1 | 2003 | 2580 | 0.030 |
Why?
|
Treatment Failure | 1 | 2014 | 337 | 0.030 |
Why?
|
Fanconi Anemia | 1 | 2013 | 44 | 0.030 |
Why?
|
Endocrine System Diseases | 1 | 2013 | 39 | 0.030 |
Why?
|
Pregnancy Complications | 1 | 2018 | 512 | 0.030 |
Why?
|
Biological Assay | 1 | 1993 | 103 | 0.030 |
Why?
|
Interferon Regulatory Factor-1 | 2 | 2003 | 15 | 0.030 |
Why?
|
Brain Edema | 1 | 2013 | 68 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 663 | 0.030 |
Why?
|
Neurologic Examination | 1 | 2013 | 193 | 0.030 |
Why?
|
Affective Symptoms | 1 | 2013 | 59 | 0.030 |
Why?
|
Pupil | 1 | 2013 | 71 | 0.030 |
Why?
|
Spondylitis | 1 | 2012 | 7 | 0.020 |
Why?
|
Medical Records | 1 | 2013 | 192 | 0.020 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2014 | 502 | 0.020 |
Why?
|
STAT1 Transcription Factor | 2 | 2003 | 73 | 0.020 |
Why?
|
Partial Pressure | 1 | 1992 | 28 | 0.020 |
Why?
|
Neoplasm Grading | 1 | 2013 | 274 | 0.020 |
Why?
|
Head Protective Devices | 1 | 2012 | 24 | 0.020 |
Why?
|
Apnea | 1 | 2012 | 31 | 0.020 |
Why?
|
Subarachnoid Hemorrhage | 1 | 2012 | 70 | 0.020 |
Why?
|
Back Pain | 1 | 2012 | 28 | 0.020 |
Why?
|
Stellate Ganglion | 1 | 2011 | 8 | 0.020 |
Why?
|
Ganglia, Sympathetic | 1 | 2011 | 23 | 0.020 |
Why?
|
Developmental Disabilities | 1 | 2017 | 712 | 0.020 |
Why?
|
Risk Assessment | 2 | 2017 | 3447 | 0.020 |
Why?
|
Atenolol | 1 | 2011 | 43 | 0.020 |
Why?
|
Observer Variation | 1 | 2012 | 299 | 0.020 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 430 | 0.020 |
Why?
|
Body Temperature | 1 | 1992 | 114 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 1284 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2014 | 882 | 0.020 |
Why?
|
Adjuvants, Anesthesia | 1 | 2011 | 7 | 0.020 |
Why?
|
Disinfection | 1 | 2011 | 26 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2013 | 762 | 0.020 |
Why?
|
Syncope | 1 | 2011 | 51 | 0.020 |
Why?
|
Intracranial Hypertension | 1 | 2012 | 119 | 0.020 |
Why?
|
Absorbable Implants | 1 | 2011 | 25 | 0.020 |
Why?
|
Pyramidal Tracts | 1 | 2011 | 35 | 0.020 |
Why?
|
Vision Disorders | 1 | 2013 | 211 | 0.020 |
Why?
|
Cell Division | 2 | 2003 | 777 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2014 | 1016 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1992 | 432 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2012 | 222 | 0.020 |
Why?
|
Estrogens | 1 | 1993 | 504 | 0.020 |
Why?
|
Gait | 1 | 2012 | 146 | 0.020 |
Why?
|
Cross-Cultural Comparison | 1 | 2011 | 59 | 0.020 |
Why?
|
Tumor Cells, Cultured | 2 | 2003 | 1062 | 0.020 |
Why?
|
Fentanyl | 1 | 2011 | 48 | 0.020 |
Why?
|
Brain Ischemia | 1 | 2013 | 258 | 0.020 |
Why?
|
Minnesota | 1 | 2011 | 134 | 0.020 |
Why?
|
ROC Curve | 1 | 2012 | 570 | 0.020 |
Why?
|
Bone Marrow Transplantation | 1 | 2013 | 573 | 0.020 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2010 | 84 | 0.020 |
Why?
|
Neoplasm Staging | 1 | 2014 | 1251 | 0.020 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2010 | 11 | 0.020 |
Why?
|
Organizational Policy | 1 | 2010 | 53 | 0.020 |
Why?
|
Ganglioneuroma | 1 | 2010 | 18 | 0.020 |
Why?
|
Antibiotic Prophylaxis | 1 | 2011 | 119 | 0.020 |
Why?
|
Electric Stimulation | 1 | 2011 | 325 | 0.020 |
Why?
|
Thoracic Neoplasms | 1 | 2010 | 38 | 0.020 |
Why?
|
Organizations | 1 | 2010 | 16 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2011 | 243 | 0.020 |
Why?
|
Surgery, Plastic | 1 | 2012 | 111 | 0.020 |
Why?
|
Postoperative Care | 1 | 2012 | 298 | 0.020 |
Why?
|
Survival Analysis | 1 | 2013 | 1499 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2010 | 356 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2010 | 279 | 0.020 |
Why?
|
Defibrillators, Implantable | 1 | 2011 | 190 | 0.020 |
Why?
|
International Cooperation | 1 | 2010 | 157 | 0.020 |
Why?
|
Frail Elderly | 1 | 2010 | 96 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 2010 | 152 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2010 | 206 | 0.020 |
Why?
|
X-Ray Microtomography | 1 | 2009 | 83 | 0.020 |
Why?
|
Trans-Activators | 2 | 2003 | 799 | 0.020 |
Why?
|
Muscle Contraction | 2 | 1986 | 188 | 0.020 |
Why?
|
Colposcopy | 1 | 2008 | 13 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2010 | 170 | 0.020 |
Why?
|
Cerebrovascular Disorders | 1 | 1989 | 122 | 0.020 |
Why?
|
Disease Progression | 1 | 2014 | 2049 | 0.020 |
Why?
|
Anthropometry | 1 | 2009 | 199 | 0.020 |
Why?
|
Patient Dropouts | 1 | 2008 | 52 | 0.020 |
Why?
|
Geriatrics | 1 | 1988 | 73 | 0.020 |
Why?
|
Angioplasty | 1 | 2008 | 89 | 0.020 |
Why?
|
Nurse Practitioners | 1 | 1988 | 46 | 0.020 |
Why?
|
Transcription, Genetic | 2 | 2003 | 1697 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2014 | 1701 | 0.020 |
Why?
|
Acute Disease | 1 | 2010 | 1110 | 0.020 |
Why?
|
Surgical Mesh | 1 | 2007 | 61 | 0.020 |
Why?
|
Focus Groups | 1 | 2008 | 199 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2007 | 122 | 0.020 |
Why?
|
Internal Medicine | 1 | 1988 | 150 | 0.020 |
Why?
|
Flatulence | 1 | 2006 | 4 | 0.020 |
Why?
|
Observation | 1 | 2006 | 42 | 0.020 |
Why?
|
Perineum | 1 | 2006 | 48 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2008 | 276 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2008 | 268 | 0.020 |
Why?
|
Sexual Behavior | 1 | 2007 | 245 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2010 | 771 | 0.020 |
Why?
|
Stroke | 1 | 2013 | 986 | 0.020 |
Why?
|
Pediatrics | 1 | 2014 | 1166 | 0.020 |
Why?
|
Physical Exertion | 1 | 1985 | 80 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1985 | 256 | 0.010 |
Why?
|
Absenteeism | 1 | 2004 | 20 | 0.010 |
Why?
|
Domestic Violence | 1 | 2004 | 12 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2005 | 399 | 0.010 |
Why?
|
Biomedical Research | 1 | 2010 | 519 | 0.010 |
Why?
|
5' Flanking Region | 1 | 2003 | 9 | 0.010 |
Why?
|
Anticoagulants | 1 | 2008 | 592 | 0.010 |
Why?
|
Peptide Initiation Factors | 1 | 2003 | 30 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2005 | 617 | 0.010 |
Why?
|
Interferon Regulatory Factors | 1 | 2003 | 37 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2003 | 169 | 0.010 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2003 | 82 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2008 | 607 | 0.010 |
Why?
|
Oligonucleotides, Antisense | 1 | 2003 | 78 | 0.010 |
Why?
|
Oligonucleotides | 1 | 2002 | 89 | 0.010 |
Why?
|
Defecography | 1 | 2002 | 2 | 0.010 |
Why?
|
Pilot Projects | 1 | 2006 | 1391 | 0.010 |
Why?
|
Sampling Studies | 1 | 2002 | 77 | 0.010 |
Why?
|
Signal Transduction | 1 | 2014 | 4493 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2005 | 870 | 0.010 |
Why?
|
Methods | 1 | 1981 | 149 | 0.010 |
Why?
|
Hypophysectomy | 1 | 2001 | 20 | 0.010 |
Why?
|
Cues | 1 | 1981 | 92 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2003 | 502 | 0.010 |
Why?
|
Pituitary Gland | 1 | 2001 | 82 | 0.010 |
Why?
|
Transfection | 1 | 2003 | 1061 | 0.010 |
Why?
|
Mice | 2 | 2014 | 17577 | 0.010 |
Why?
|
Binding Sites | 1 | 2003 | 1295 | 0.010 |
Why?
|
Imitative Behavior | 1 | 2000 | 5 | 0.010 |
Why?
|
NF-kappa B | 1 | 2002 | 455 | 0.010 |
Why?
|
Databases as Topic | 1 | 2000 | 71 | 0.010 |
Why?
|
Hepatitis B Surface Antigens | 1 | 1999 | 51 | 0.010 |
Why?
|
Protein Binding | 1 | 2003 | 1736 | 0.010 |
Why?
|
Immunoblotting | 1 | 1999 | 311 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2002 | 1327 | 0.010 |
Why?
|
Virion | 1 | 1999 | 147 | 0.010 |
Why?
|
Phosphorylation | 1 | 2002 | 1614 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2001 | 1883 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2002 | 1893 | 0.010 |
Why?
|
Diethylstilbestrol | 1 | 1993 | 142 | 0.010 |
Why?
|
Estradiol | 1 | 1993 | 531 | 0.010 |
Why?
|
Phenotype | 1 | 1999 | 4255 | 0.010 |
Why?
|
Sensory Thresholds | 1 | 1989 | 35 | 0.000 |
Why?
|
Proprioception | 1 | 1989 | 20 | 0.000 |
Why?
|
Relaxation Therapy | 1 | 1985 | 14 | 0.000 |
Why?
|
Mental Status Schedule | 1 | 1985 | 44 | 0.000 |
Why?
|
Abdominal Muscles | 1 | 1985 | 27 | 0.000 |
Why?
|
Electrophysiology | 1 | 1985 | 270 | 0.000 |
Why?
|